EPIRUS Biopharmaceuticals, Inc. Share Price

Stocks

Delayed OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

09/10/18	Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	CI
30/01/18	Praxis Precision Medicines, Inc. completed the acquisition of Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q).	CI

09/10/18	Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	CI
30/01/18	Praxis Precision Medicines, Inc. completed the acquisition of Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q).	CI
19/01/18	Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	CI
17/01/18	Praxis Precision Medicines, Inc. agreed to acquire Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q) for $1 million.	CI
11/12/17	Notice of Intent of Asset Sale Filed by EPIRUS Biopharmaceuticals, Inc.	CI
19/09/16	Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	CI
05/08/16	EPIRUS Biopharmaceuticals, Inc.(OTCPK:EPRS.Q) dropped from S&P TMI Index	CI
03/08/16	EPIRUS Biopharmaceuticals, Inc.(OTCPK:EPRS.Q) dropped from NASDAQ Composite Index	CI
25/07/16	EPIRUS Biopharmaceuticals, Inc. Announces Management Resignations	CI
25/07/16	EPIRUS Biopharmaceuticals, Inc. Filed for Bankruptcy	CI
01/07/16	EPIRUS Biopharmaceuticals, Inc. Announces Executive Termination	CI
29/06/16	Polpharma S.A. completed the acquisition of EPIRUS Biopharmaceuticals (Netherlands) B.V. from EPIRUS Biopharmaceuticals, Inc..	CI
13/06/16	Polpharma S.A. entered into a binding term sheet to acquire EPIRUS Biopharmaceuticals (Netherlands) B.V. from EPIRUS Biopharmaceuticals, Inc. for $3.5 million.	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
EPIRUS BIOPHARMACEUTICALS, INC.	-.--%	-.--%	-	-	26
WUXI APPTEC CO., LTD.	+4.16%	-0.36%	+49.37%	+94.17%	74.46B
ARGENX SE	-0.24%	+1.20%	+27.73%	+80.90%	60.14B
LONZA GROUP AG	-1.32%	-0.42%	+6.17%	+34.98%	48.15B
IQVIA HOLDINGS INC.	-0.05%	+0.37%	+41.54%	+36.65%	44.25B
REVOLUTION MEDICINES, INC.	+0.38%	+7.61%	+339.53%	+641.55%	43.99B
BEONE MEDICINES AG	+0.18%	+0.26%	+7.41%	+103.45%	41.61B
CELLTRION, INC.	-0.67%	+0.17%	+7.60%	+46.37%	29.97B
WUXI BIOLOGICS (CAYMAN) INC.	+4.77%	+6.16%	+36.77%	+22.78%	29.31B
INSMED INCORPORATED	-1.29%	-3.55%	-20.74%	+352.04%	24.93B
Average	+0.60%	+1.38%	+55.04%	+156.99%	39.68B
Weighted average by Cap.	+0.87%	+1.53%	+59.26%	+147.54%